Helen C. Adams's most recent trade in Immix Biopharma Inc was a trade of 12,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 22, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immix Biopharma Inc | Helen C. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2026 | 12,500 | 12,500 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Helen C. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2026 | 6,250 | 181,004 | - | 0 | Common Stock | |
| Immix Biopharma Inc | Helen C. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Helen C. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Immix Biopharma Inc | Helen C. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 87,740 | 100,740 | - | 0 | Common Stock | |
| Immix Biopharma Inc | Helen C. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 74,241 | 174,754 | - | - | Common Stock | |
| Immix Biopharma Inc | Helen C. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2023 | 20,000 | 20,000 | - | - | Stock Options | |
| Immix Biopharma Inc | Helen C. Adams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2022 | 16,000 | 53,500 | - | - | Stock Options |